Novel pancreatic cancer vaccine nudging survival rates higher
19th Nov 2005, 21:12 GMT
A novel vaccine for pancreatic cancer appears to be nudging survival rates higher, say researchers at Johns Hopkins University School of Medicine. Their study, the first reported phase II study of a vaccine to treat this often lethal disease following surgery, has found in an early analysis that 88 percent of 56 patients tested are alive a year after treatment, and that two year survival is 76 percent... click link for more info.
Novel pancreatic cancer vaccine nudging survival rates higher related news:
- Trials show cancer vaccine promising — NYNewsday.com Health and Science headlines
- Cancer vaccine promising — baltimoresun.com - nation/world
- Testicular Cancer Survivors Have Higher Rates of Other Cancers (American Cancer Society) — Yahoo! News: Health News
- In the U.S. 40,000 People Died from Metastatic Breast Cancer in 2003, with Median Survival Rates Estimated to be Two Years — PR Web (The Free Wire Service) Medical Cancer
- Scottish women, who have high incidence of cervical cancer, given vaccine — The Cancer Blog
- Melanoma vaccine — MedTerms Word of the Day
- Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety Concerns — Medical News Today RSS/XML Feed
- Scots teenagers first to test cervical cancer vaccine — Scotsman.com News
- Killing regulatory T cells boosts effectiveness of cancer vaccine — EurekAlert! - Medicine and Health
- Study Examines Effect of Hysterectomy on Endometrial Cancer Rates — Medical News Today RSS/XML Feed
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes